Induction of psoriatic scalp and nail lesions in a patient treated with Ofatumumab: A potential autoimmune dysregulation induced by anti-CD 20 therapy

Skin Res Technol. 2024 Mar;30(3):e13662. doi: 10.1111/srt.13662.

Authors

Astrid Herzum¹, Silvia Maria Orsi², Giulia Ciccarese³, Corrado Occella¹, Gianmaria Viglizzo¹

Affiliations

¹ Dermatology Department, IRCCS Istituto Giannina Gaslini, Genova, Italy.
² Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
³ Dermatology Unit, Department of Medical and Surgical Sciences, University of Foggia and Ospedali Riuniti, Foggia, Italy.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Nail Diseases* / chemically induced
Nail Diseases* / drug therapy
Nails / pathology
Psoriasis* / chemically induced
Psoriasis* / drug therapy
Psoriasis* / pathology
Scalp / pathology

Substances

ofatumumab
Antibodies, Monoclonal, Humanized